PB-GG-OCT4-1-5-PGK-Puro Citations (1)
Originally described in: Human pluripotent reprogramming with CRISPR activators.Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti EM, Trokovic R, Kere J, Otonkoski T Nat Commun. 2018 Jul 6;9(1):2643. doi: 10.1038/s41467-018-05067-x. PubMed Journal
Articles Citing PB-GG-OCT4-1-5-PGK-Puro
| Articles |
|---|
| Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma. Routila J, Qiao X, Weltner J, Rantala JK, Carpen T, Hagstrom J, Makitie A, Leivo I, Ruuskanen M, Soderlund J, Rintala M, Hietanen S, Irjala H, Minn H, Westermarck J, Ventela S. Oral Oncol. 2022 Apr;127:105772. doi: 10.1016/j.oraloncology.2022.105772. Epub 2022 Mar 1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.